These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4384076)

  • 1. Urinary and gastrointestinal excretion of metabolites of labelled 5-hydroxytryptamine and 5-hydroxytryptophan.
    Airaksinen MM; Mattila K
    Acta Pharmacol Toxicol (Copenh); 1967; 25(4):473-82. PubMed ID: 4384076
    [No Abstract]   [Full Text] [Related]  

  • 2. Uptake and storage mechanism of 5-hydroxytryptamine in rabbit brain stem and effect of reserpine.
    Takatsuka K; Segawa T; Takagi H
    Jpn J Pharmacol; 1971 Feb; 21(1):57-67. PubMed ID: 4403263
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism of serotonin by the isolated perfused rat liver--effect of glucuronyl transferase deficiency or monoamine oxidase inhibition.
    Tyce GM; Flock EV; Owen CA
    Biochem Pharmacol; 1968 Aug; 17(8):1543-52. PubMed ID: 4386234
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of reserpine and desipramine on the uptake and subcellular distribution of 5-hydroxytryptamine in rabbit brain stem after intravenous administration of 5-hydroxytryptophan.
    Segawa T
    Jpn J Pharmacol; 1970 Mar; 20(1):87-91. PubMed ID: 4393817
    [No Abstract]   [Full Text] [Related]  

  • 5. Radioisotopic studies of the binding, exchange, and distribution of 5-hydroxytryptamine synthesized from its radioactive precursor.
    Gershon MD; Ross LL
    J Physiol; 1966 Oct; 186(2):451-76. PubMed ID: 5298336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The disposition and metabolism of tryptamine and the in vivo formation of 6-hydroxytryptamine in the rabbit.
    Lemberger L; Axelrod J; Kopin IJ
    J Pharmacol Exp Ther; 1971 Apr; 177(1):169-76. PubMed ID: 4398046
    [No Abstract]   [Full Text] [Related]  

  • 7. New degradative routes of 5-hydroxytryptophan and serotonin by intestinal tryptophan 2,3-dioxygenase.
    Hirata F; Hayaishi O
    Biochem Biophys Res Commun; 1972 Jun; 47(5):1112-9. PubMed ID: 4537396
    [No Abstract]   [Full Text] [Related]  

  • 8. Spectrum analysis of electroencephalographic changes induced by some psychoactive agents. Their possible relationship to changes in cerebral biogenic amine levels.
    Eidelberg E; Miller MK; Long M
    Int J Neuropharmacol; 1966 Jan; 5(1):59-74. PubMed ID: 4380483
    [No Abstract]   [Full Text] [Related]  

  • 9. The possible mechanism for the 'fade' in acid gastric secretion during continuous infusions of pentagastrin.
    Sanyal AK; Waton NG
    J Physiol; 1976 Oct; 261(2):445-51. PubMed ID: 978581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An autoradiographic study of incorporation of labelled 5-hydroxytryptophan and 5-hydroxytryptamine in the brain].
    Kaneda M
    Arch Histol Jpn; 1967 Apr; 28(2):207-25. PubMed ID: 5298492
    [No Abstract]   [Full Text] [Related]  

  • 11. The metabolism of 5-hydroxytryptamine by blood platelets from children with mongolism.
    Boullin DJ; O'Brien RA
    Biochem Pharmacol; 1973 Jul; 22(13):1647-51. PubMed ID: 4269711
    [No Abstract]   [Full Text] [Related]  

  • 12. Functional aspects of 5-hydroxytryptamine turnover in the central nervous system.
    Modigh K
    Acta Physiol Scand Suppl; 1974; 403():1-56. PubMed ID: 4275711
    [No Abstract]   [Full Text] [Related]  

  • 13. Removal of 5-hydroxytryptamine by rat isolated lung.
    Alabaster VA; Bakhle YS
    Br J Pharmacol; 1970 Feb; 38(2):440P-441P. PubMed ID: 5417869
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition.
    Butcher LL; Engel J; Fuxe K
    Brain Res; 1972 Jun; 41(2):387-411. PubMed ID: 4402607
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of oral 5-HTP administration on 5-HTP and 5-HT immunoreactivity in monoaminergic brain regions of rats.
    Lynn-Bullock CP; Welshhans K; Pallas SL; Katz PS
    J Chem Neuroanat; 2004 May; 27(2):129-38. PubMed ID: 15121217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The action of 5-hydroxytryptamine, 5-hydroxytryptophan and reserpine on intestinal peristalsis in anaesthetized guinea-pigs.
    BULBRING E; CREMA A
    J Physiol; 1959 Apr; 146(1):29-53. PubMed ID: 13655214
    [No Abstract]   [Full Text] [Related]  

  • 17. Serotonin metabolism in patients with carcinoid tumors: incidence of 5-hydroxytryptophan-secreting tumors.
    Feldman JM
    Gastroenterology; 1978 Dec; 75(6):1109-14. PubMed ID: 309417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective protection of serotonin stores against the action of reserpine by -methyl-5-hydroxytryptpohan pretreatment.
    Lahti RA; Platz PA
    Biochem Pharmacol; 1969 Oct; 18(10):2363-9. PubMed ID: 4397869
    [No Abstract]   [Full Text] [Related]  

  • 19. Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase.
    Bartholini G; Da Prada M; Pletscher A
    J Pharm Pharmacol; 1968 Mar; 20(3):228-9. PubMed ID: 4385052
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined autoradiography and fluorescence microscopy. Localization of labelled 5-hydroxytryptophan in relation to endogenous 5-hydroxytryptamine in the gastrointestinal tract.
    Hammarström L; Ritzén M; Ullberg S
    Experientia; 1966 Apr; 22(4):213-5. PubMed ID: 5297292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.